Glass House Brands Inc.
GLASHealthcareNASDAQDrug Manufacturers - Specialty & Generic · Last scanned Jul 17, 2026
Glass House Brands Inc., together with its subsidiaries, operates as an integrated cannabis company in the United States. With a market capitalization of $927.3M, it sits in small-cap territory. It operates through three segments: Retail; Wholesale Biomass; and Cannabis-Related Consumer Packaged Goods.
Market Cap
$927.3M
Beta
0.51
P/E (TTM)
—
P/E (Fwd)
39.02
EPS (TTM)
$-0.57
EPS (Fwd)
$0.27
ROE
-20.4%
ROA
-5.3%
Cash
$24.4M
Total Debt
$75.0M
Free CF
-$26.1M
52W Change
81.4%
Annual Financials
Cash vs Debt
Glass House Brands Inc. carries $75.0M in total debt against $24.4M in cash reserves — debt is roughly 3.1x the cash position. Managing this leverage effectively will be important for long-term financial stability. The company is burning cash, with free cash flow at -$26.1M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. ROE of -20.4% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has grown from $84.9M (2022) to $182.0M (2025), reflecting a 114% increase over the period.
GLAS's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Glass House Brands Inc.'s trajectory.